Biosimilars News

Sandoz aims to more than double its annual net sales by 2035, with biosimilars driving this growth, and plans to expand its biosimilar portfolio to 100 drugs by

Cipla has announced a partnership with China's Qilu Pharma to develop and commercialize a cancer biosimilar, reinforcing Cipla's focus on its oncology portfolio

Dr Reddy's, a pharmaceutical company, is now focusing on biosimilars and innovation to sustain growth after achieving record profits from a single copycat drug.

Thermo Fisher Scientific is increasing its investment in India, driven by the anticipated growth in biosimilars and innovative medicines, with Indian pharmaceut

Biocon's Kiran Mazumdar-Shaw believes US generics tariffs are more of a negotiation tactic than a real threat, with the company exploring potential manufacturin

Biocon reported a 9% year-on-year rise in Q1 total income to 4,391 crore rupees for FY27, with biopharma revenue increasing by 17%. The company's EBITDA stood a

The healthcare sector anticipates strong growth in domestic formulations and emerging markets, with companies less dependent on US generics likely to see broad-